News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Reconstructing the Path of a Seizure
December 3, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Spectradyne: SBIR Funding Spurs Advances in Nanoparticle Technology
November 19, 2024 - NCATS News
- Small Business (SBIR)
NCATS small business innovation research funding helped Spectradyne, LLC, commercialize an improved nanoparticle analyzer critical to research and drug development.
Read ArticleNew Path for a Gene Therapy Trial at NIH for a Rare Metabolic Disease
November 19, 2024 - NCATS News
- Bespoke Gene Therapy Consortium (BGTC)
- Our Impact on Clinical Trials
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
- Platform Vector Gene Therapy (PaVe-GT)
Scientists at NCATS and other NIH institutes and centers are teaming up to advance a gene therapy treatment for MMA, a rare and potentially life-threatening genetic disorder.
Study Identifies Strategy for AI Cost-Efficiency in Health Care Settings
November 18, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Azome Therapeutics Enters Into CRADA With National Center for Advancing Translational Sciences to Investigate Novel Inflammasome Antagonist to Prevent Bronchopulmonary Dysplasia
November 13, 2024 - Grantee/Partner News
- Our Impact on Drug Discovery and Development
Why Is Asthma More Challenging for Arkansas Children? ACRI/UAMS Researcher Aims to Find Out With NIH Funding
November 13, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Easing the Burden of Rare Diseases Through Translational Science
November 12, 2024 - NCATS News
- Our Impact on Rare Diseases
NCATS Director Joni Rutter discusses how NCATS is addressing scientific and operational roadblocks that slow progress for rare diseases research and treatments.
How New Therapies Are Revolutionizing the Treatment of Juvenile Idiopathic Arthritis
November 12, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program